| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.006 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.006 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |